Medicago, a Canadian vaccine maker, which has a plant in Durham, has netted a $15 million loan from an
unnamed pharma partner. The agreement
that could include co-promotion rights of Medicago vaccines in certain markets.
If a licensing agreement can be made, the principal of the loan would be applied
as up-front payments, and Medicago would not have to pay interest.
No comments:
Post a Comment